Clinical Trial Update: Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the immunogenicity and interchangeability of two inactivated Hepatitis A vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Inactivated Hepatitis A vaccine (formulation 1)
• Inactivated Hepatitis A vaccine (formulation 2)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hepatitis A | Phase 4 | Status: COMPLETED